For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death
Verified: 2 outlets in 2 countries have reported this story since Nov 10.
People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
- Nov 10, 4:24 PM UTCFirst reportQuitting diabetes drugs doubles stroke and heart risk: studybdnews24.com ↗
- Nov 11, 6:25 AM UTC+14 h· you’re reading thisFor diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, deatheuronews.com ↗
- Severity rose to medium
- Verified: a second independent outlet reported itNov 11, 6:25 AM UTC · +14 h
[Claude] Report 2 covers the same study on people with type 2 diabetes who stopped GLP-1 treatment and their doubled risk of heart attack, stroke or death, with no conflicting facts.
1h agoOnly 1 source — pending corroboration
1h agoSingle timestamp
1h agoAverage source trust: 50%; Source tiers represented: national
1h agoNo authoritative sources yet — awaiting wire/institutional coverage
1h agoFor diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.
Score bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Moderate · How we score this